Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Aug;93(2):139–141. doi: 10.1111/j.1365-2249.1993.tb07955.x

Pitfalls in the measurement of soluble forms of cell surface receptors.

N R Ling
PMCID: PMC1554849  PMID: 8348738

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bazil V., Strominger J. L. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol. 1991 Sep 1;147(5):1567–1574. [PubMed] [Google Scholar]
  2. Engelmann H., Aderka D., Rubinstein M., Rotman D., Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem. 1989 Jul 15;264(20):11974–11980. [PubMed] [Google Scholar]
  3. Fischer E., Delibrias C., Kazatchkine M. D. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol. 1991 Feb 1;146(3):865–869. [PubMed] [Google Scholar]
  4. Gaillard J. P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., Maruo N., Taga T., Kishimoto T., Klein B. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol. 1993 Apr;23(4):820–824. doi: 10.1002/eji.1830230408. [DOI] [PubMed] [Google Scholar]
  5. Gamble J. R., Skinner M. P., Berndt M. C., Vadas M. A. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science. 1990 Jul 27;249(4967):414–417. doi: 10.1126/science.1696029. [DOI] [PubMed] [Google Scholar]
  6. Graber P., Jansen K., Pochon S., Shields J., Aubonney N., Turcatti G., Bonnefoy J. Y. Purification and characterization of biologically active human recombinant 37 kDa soluble CD23 (sFc epsilon RII) expressed in insect cells. J Immunol Methods. 1992 May 18;149(2):215–226. doi: 10.1016/0022-1759(92)90253-p. [DOI] [PubMed] [Google Scholar]
  7. Haziot A., Chen S., Ferrero E., Low M. G., Silber R., Goyert S. M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol. 1988 Jul 15;141(2):547–552. [PubMed] [Google Scholar]
  8. Huemer H. P., Larcher C., Prodinger W. M., Petzer A. L., Mitterer M., Falser N. Determination of soluble CD21 as a parameter of B cell activation. Clin Exp Immunol. 1993 Aug;93(2):195–199. doi: 10.1111/j.1365-2249.1993.tb07965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ida N., Sakurai S., Hosoi K., Kunitomo T. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. J Immunol Methods. 1992 Nov 25;156(1):27–38. doi: 10.1016/0022-1759(92)90007-g. [DOI] [PubMed] [Google Scholar]
  10. Johnston G. I., Cook R. G., McEver R. P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell. 1989 Mar 24;56(6):1033–1044. doi: 10.1016/0092-8674(89)90636-3. [DOI] [PubMed] [Google Scholar]
  11. Josimovic-Alasevic O., Dürkop H., Schwarting R., Backé E., Stein H., Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol. 1989 Jan;19(1):157–162. doi: 10.1002/eji.1830190125. [DOI] [PubMed] [Google Scholar]
  12. Kalinkovich A., Engelmann H., Harpaz N., Burstein R., Barak V., Kalickman I., Wallach D., Bentwich Z. Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol. 1992 Sep;89(3):351–355. doi: 10.1111/j.1365-2249.1992.tb06961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Khayat D., Dux Z., Anavi R., Shlomo Y., Witz I. P., Ran M. Circulating cellfree Fc gamma 2b/gamma 1 receptor in normal mouse serum: its detection and specificity. J Immunol. 1984 May;132(5):2496–2501. [PubMed] [Google Scholar]
  14. Ling N. R., Brown B. Properties of soluble CR2 in human serum. Immunobiology. 1992 Aug;185(2-4):403–414. doi: 10.1016/S0171-2985(11)80656-X. [DOI] [PubMed] [Google Scholar]
  15. Ling N. R., Stevenson F. K., Brown B. Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL) Clin Exp Immunol. 1991 Dec;86(3):360–366. doi: 10.1111/j.1365-2249.1991.tb02938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ling N., Hansel T., Richardson P., Brown B. Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia. Clin Exp Immunol. 1991 Apr;84(1):16–22. doi: 10.1111/j.1365-2249.1991.tb08117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Marcon L., Fritz M. E., Kurman C. C., Jensen J. C., Nelson D. L. Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL). Clin Exp Immunol. 1988 Jul;73(1):29–33. [PMC free article] [PubMed] [Google Scholar]
  18. Mosley B., Beckmann M. P., March C. J., Idzerda R. L., Gimpel S. D., VandenBos T., Friend D., Alpert A., Anderson D., Jackson J. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell. 1989 Oct 20;59(2):335–348. doi: 10.1016/0092-8674(89)90295-x. [DOI] [PubMed] [Google Scholar]
  19. Murata Y., Takaki S., Migita M., Kikuchi Y., Tominaga A., Takatsu K. Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med. 1992 Feb 1;175(2):341–351. doi: 10.1084/jem.175.2.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Myones B. L., Ross G. D. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site. Complement. 1987;4(2):87–98. doi: 10.1159/000463012. [DOI] [PubMed] [Google Scholar]
  21. Müllberg J., Schooltink H., Stoyan T., Günther M., Graeve L., Buse G., Mackiewicz A., Heinrich P. C., Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol. 1993 Feb;23(2):473–480. doi: 10.1002/eji.1830230226. [DOI] [PubMed] [Google Scholar]
  22. Nemerow G. R., Mullen J. J., 3rd, Dickson P. W., Cooper N. R. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection. J Virol. 1990 Mar;64(3):1348–1352. doi: 10.1128/jvi.64.3.1348-1352.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Norment A. M., Littman D. R. A second subunit of CD8 is expressed in human T cells. EMBO J. 1988 Nov;7(11):3433–3439. doi: 10.1002/j.1460-2075.1988.tb03217.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Novick D., Engelmann H., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med. 1989 Oct 1;170(4):1409–1414. doi: 10.1084/jem.170.4.1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parnes J. R. Molecular biology and function of CD4 and CD8. Adv Immunol. 1989;44:265–311. doi: 10.1016/s0065-2776(08)60644-6. [DOI] [PubMed] [Google Scholar]
  26. Rothlein R., Mainolfi E. A., Czajkowski M., Marlin S. D. A form of circulating ICAM-1 in human serum. J Immunol. 1991 Dec 1;147(11):3788–3793. [PubMed] [Google Scholar]
  27. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  28. Seth R., Raymond F. D., Makgoba M. W. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet. 1991 Jul 13;338(8759):83–84. doi: 10.1016/0140-6736(91)90077-3. [DOI] [PubMed] [Google Scholar]
  29. Spertini O., Schleiffenbaum B., White-Owen C., Ruiz P., Jr, Tedder T. F. ELISA for quantitation of L-selectin shed from leukocytes in vivo. J Immunol Methods. 1992 Nov 25;156(1):115–123. doi: 10.1016/0022-1759(92)90017-n. [DOI] [PubMed] [Google Scholar]
  30. Symons J. A., Eastgate J. A., Duff G. W. Purification and characterization of a novel soluble receptor for interleukin 1. J Exp Med. 1991 Nov 1;174(5):1251–1254. doi: 10.1084/jem.174.5.1251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tavernier J., Devos R., Cornelis S., Tuypens T., Van der Heyden J., Fiers W., Plaetinck G. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell. 1991 Sep 20;66(6):1175–1184. doi: 10.1016/0092-8674(91)90040-6. [DOI] [PubMed] [Google Scholar]
  32. Yoon S. H., Fearon D. T. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol. 1985 May;134(5):3332–3338. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES